Literature DB >> 31100679

Extract of Ilex rotunda Thunb alleviates experimental colitis-associated cancer via suppressing inflammation-induced miR-31-5p/YAP overexpression.

Gang Chen1, Yueqing Han1, Yuan Feng1, Aiping Wang2, Xuezheng Li3, Song Deng2, Lin Zhang1, Jiao Xiao1, Yanwu Li4, Ning Li5.   

Abstract

BACKGROUND: Ilex rotunda Thunb is a traditional medicine used in China treating colitis clinically. Triterpenoids is one of its main components. However, the detailed pharmacological activity and the component responsible for its clinical effects are still elusive.
PURPOSE: To test the in vivo colitis-associated cancer (CAC) preventive effect of the water fraction extracted from the roots of I. rotunda, and to evaluate its microRNA (miRNA)-related mechanism. STUDY DESIGN AND METHODS: Male or female C57BL/6 mice (12 weeks of age) were used to construct the azoxymethane (AOM)/dextran sulfate sodium (DSS)-induced CAC. 12.5 mg/kg and 25.0 mg/kg of the standardized water extract of I. rotunda (WIR), being equal to 4.29 and 8.58 g of the raw medicine respectively, were adopted to treat the AOM/DSS-induced CAC from the fourth week and continued for 5 weeks. Mice were killed two weeks after the end of the last round of DSS by cervical dislocation.
RESULTS: The chemical analysis of WIR revealed the presence of 21 compounds. The syringing and caffeic acid (1-hydroxyl-4-O-β-D-glucopyranosylprenyl)-ester are the main components of WIR, counting for 8.27% and 5.71% of the water extract respectively. The levels of miR-31-5p were up-regulated in both thp1 and Caco2 cells (p < 0.05) stimulated by either IL-6 or TNF-α, and WIR could restore miR-31-5p levels in the IL-6/TNF-α-stimulated thp-1 and Caco2 cells. Furthermore, WIR decreased TNF-α and IL-6 levels in PMA-differentiated thp-1 cells stimulated by LPS via NF-κB pathway (p < 0.05), suggesting that WIR could restore miR-31-5p expression via down-regulating IL-6 and TNF-α levels. In vivo study showed that oral administration of WIR (25 mg/kg) produced a significant inhibition on the atypical hyperplasia, as well as the release and the expression of IL-6 and TNF-α in the colon tissue. The in vivo transcription of other pro-inflammatory mediators such as iNOS, IL-11, and IL-17A were also attenuated by WIR administration (25 mg/kg, p < 0.05). Meanwhile, WIR (25 mg/kg) restored the miR-31-5p level which was up-regulated in the CAC model group, and ectopic expressions of the miR-31-5p down-stream LATS2 and YAP genes in the hippo pathway were also modulated by the WIR (25 mg/kg) treatment.
CONCLUSION: The present study suggests that WIR exerts intestinal anti-inflammatory and CAC preventive effects in an experimental CAC mouse model. The CAC preventive effect can be attributed to the suppression of hippo pathway activated by the inflammatory cytokines, indicating that WIR can be potentially used as an herbal product for CAC prevention. Therefore, there is an emergent need for further evaluation of the main components in WIR to determine the definite bioactive component responsible for the CAC preventive activity.
Copyright © 2019 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Colitis associated cancer; Hippo pathway; Ilex rotunda Thunb; MicroRNAs; colorectal cancer

Mesh:

Substances:

Year:  2019        PMID: 31100679     DOI: 10.1016/j.phymed.2019.152941

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  10 in total

1.  Identification of hub genes and pathways in colitis-associated colon cancer by integrated bioinformatic analysis.

Authors:  Yongming Huang; Xiaoyuan Zhang; Yansen Li; Jie Yao
Journal:  BMC Genom Data       Date:  2022-06-22

2.  Protective effect of valerian extract capsule (VEC) on ethanol- and indomethacin-induced gastric mucosa injury and ameliorative effect of VEC on gastrointestinal motility disorder.

Authors:  Yuan Feng; Wan Dai; Junyu Ke; Yong Cui; Shuang Li; Jingjing Ma; Wenfeng Guo; Gang Chen; Ning Li; Yanwu Li
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

3.  MicroRNA expression profile of chicken cecum in different stages during Histomonas meleagridis infection.

Authors:  Yu-Ming Zhang; Qiao-Guang Chen; Chen Chen; Shuang Wang; Zai-Fan Li; Zhao-Feng Hou; Dan-Dan Liu; Jian-Ping Tao; Jin-Jun Xu
Journal:  BMC Vet Res       Date:  2022-06-11       Impact factor: 2.792

Review 4.  Epigenetics/epigenomics of triterpenoids in cancer prevention and in health.

Authors:  Shanyi Li; Hsiao-Chen Dina Kuo; Ran Yin; Renyi Wu; Xia Liu; Lujing Wang; Rasika Hudlikar; Rebecca Mary Peter; Ah-Ng Kong
Journal:  Biochem Pharmacol       Date:  2020-02-29       Impact factor: 5.858

5.  TRAF6-Mediated Inflammatory Cytokines Secretion in LPS-induced Colorectal Cancer Cells Is Regulated by miR-140.

Authors:  Guangwei Zhu; Chunlin Lin; Zhibin Cheng; Qin Wang; Robert M Hoffman; Shree Ram Singh; Yongjian Huang; Wei Zheng; Shugang Yang; Jianxin Ye
Journal:  Cancer Genomics Proteomics       Date:  2020 Jan-Feb       Impact factor: 4.069

6.  LncRNA NEAT1 Promotes Inflammatory Response in Sepsis via the miR-31-5p/POU2F1 Axis.

Authors:  Yang Yang; Jianhua Xue; Lili Qin; Jiaxuan Zhang; Jiajia Liu; Junbo Yu
Journal:  Inflammation       Date:  2021-03-12       Impact factor: 4.092

7.  The Role of miR-31-5p in the Development of Intervertebral Disc Degeneration and Its Therapeutic Potential.

Authors:  Yong Zhou; Mingsi Deng; Jiqing Su; Wei Zhang; Dongbiao Liu; Zhengguang Wang
Journal:  Front Cell Dev Biol       Date:  2021-03-18

8.  Up-regulation of circARF3 reduces blood-brain barrier damage in rat subarachnoid hemorrhage model via miR-31-5p/MyD88/NF-κB axis.

Authors:  Li Cai; Beihai Ge; Shengbo Xu; Xiangwen Chen; Hong Yang
Journal:  Aging (Albany NY)       Date:  2021-09-12       Impact factor: 5.682

9.  Salivary miR-31-5p, miR-345-3p, and miR-424-3p Are Reliable Biomarkers in Patients with Oral Squamous Cell Carcinoma.

Authors:  Beáta Scholtz; József Horváth; Ildikó Tar; Csongor Kiss; Ildikó J Márton
Journal:  Pathogens       Date:  2022-02-09

10.  Luteolin suppresses the growth of colon cancer cells by inhibiting the IL-6/STAT3 signaling pathway.

Authors:  Jingwen Jiang; Fengting Zhu; Hui Zhang; Tao Sun; Fangfang Fu; Xuewu Chen; Yanhong Zhang
Journal:  J Gastrointest Oncol       Date:  2022-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.